FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042111313> ?p ?o ?g. }

• W2042111313 endingPage "172" @default.
• W2042111313 startingPage "164" @default.
• W2042111313 abstract "The present study describes the cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV protease inhibitor currently in phase III clinical trials.BI 201335 showed a good Caco-II permeability (8.7 × 10−6 cm/sec) and in vitro metabolic stability (predicted hepatic clearence (CLhep) <19% Qh in all species tested).Single dose PK revealed a clearance of 17, 3.0 and 2.6 mL/min/kg in rat, monkey and dog respectively, with a corresponding oral bioavailability of 29.1, 25.5 and 35.6%.Comparative plasma and liver PK profile in rodents showed a high liver Kp in the rat (42-fold), suggesting high target tissue distribution.Simple allometry based on animal PK predicted a human oral CL/F of 168 mL/min, within two-fold of the observed value (118 mL/min) at 240 mg in healthy volunteers.Allometry of volume of distribution generated a low exponent of 0.59, and a much lower predicted Vss/F (5-fold less than observed). Several different approaches of Vss/F prediction were evaluated ..." @default.
• W2042111313 created "2016-06-24" @default.
• W2042111313 creator A5000492972 @default.
• W2042111313 creator A5003812927 @default.
• W2042111313 creator A5006526009 @default.
• W2042111313 creator A5019243665 @default.
• W2042111313 creator A5024213444 @default.
• W2042111313 creator A5030002656 @default.
• W2042111313 creator A5034876716 @default.
• W2042111313 creator A5046591341 @default.
• W2042111313 creator A5047549350 @default.
• W2042111313 creator A5051746986 @default.
• W2042111313 creator A5067962357 @default.
• W2042111313 creator A5071871116 @default.
• W2042111313 creator A5077629868 @default.
• W2042111313 creator A5089434544 @default.
• W2042111313 date "2011-10-11" @default.
• W2042111313 modified "2023-09-27" @default.
• W2042111313 title "Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor" @default.
• W2042111313 cites W1481859140 @default.
• W2042111313 cites W1622437624 @default.
• W2042111313 cites W1939121468 @default.
• W2042111313 cites W1973376188 @default.
• W2042111313 cites W1986680170 @default.
• W2042111313 cites W1995753428 @default.
• W2042111313 cites W2018976100 @default.
• W2042111313 cites W2021199098 @default.
• W2042111313 cites W2023732225 @default.
• W2042111313 cites W2027179985 @default.
• W2042111313 cites W2033163551 @default.
• W2042111313 cites W2039202029 @default.
• W2042111313 cites W2043996867 @default.
• W2042111313 cites W2046726491 @default.
• W2042111313 cites W2057065474 @default.
• W2042111313 cites W2077937196 @default.
• W2042111313 cites W2091937293 @default.
• W2042111313 cites W2117718017 @default.
• W2042111313 cites W2136008225 @default.
• W2042111313 cites W2138788149 @default.
• W2042111313 cites W2140369033 @default.
• W2042111313 cites W2142684817 @default.
• W2042111313 cites W2143278579 @default.
• W2042111313 cites W2147031742 @default.
• W2042111313 cites W2169406601 @default.
• W2042111313 cites W2325769703 @default.
• W2042111313 cites W4230386810 @default.
• W2042111313 doi "https://doi.org/10.3109/00498254.2011.611546" @default.
• W2042111313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21988548" @default.
• W2042111313 hasPublicationYear "2011" @default.
• W2042111313 type Work @default.
• W2042111313 sameAs 2042111313 @default.
• W2042111313 citedByCount "13" @default.
• W2042111313 countsByYear W20421113132012 @default.
• W2042111313 countsByYear W20421113132013 @default.
• W2042111313 countsByYear W20421113132014 @default.
• W2042111313 countsByYear W20421113132015 @default.
• W2042111313 crossrefType "journal-article" @default.
• W2042111313 hasAuthorship W2042111313A5000492972 @default.
• W2042111313 hasAuthorship W2042111313A5003812927 @default.
• W2042111313 hasAuthorship W2042111313A5006526009 @default.
• W2042111313 hasAuthorship W2042111313A5019243665 @default.
• W2042111313 hasAuthorship W2042111313A5024213444 @default.
• W2042111313 hasAuthorship W2042111313A5030002656 @default.
• W2042111313 hasAuthorship W2042111313A5034876716 @default.
• W2042111313 hasAuthorship W2042111313A5046591341 @default.
• W2042111313 hasAuthorship W2042111313A5047549350 @default.
• W2042111313 hasAuthorship W2042111313A5051746986 @default.
• W2042111313 hasAuthorship W2042111313A5067962357 @default.
• W2042111313 hasAuthorship W2042111313A5071871116 @default.
• W2042111313 hasAuthorship W2042111313A5077629868 @default.
• W2042111313 hasAuthorship W2042111313A5089434544 @default.
• W2042111313 hasConcept C104317684 @default.
• W2042111313 hasConcept C110121322 @default.
• W2042111313 hasConcept C112705442 @default.
• W2042111313 hasConcept C121332964 @default.
• W2042111313 hasConcept C125287762 @default.
• W2042111313 hasConcept C132379496 @default.
• W2042111313 hasConcept C134306372 @default.
• W2042111313 hasConcept C135763542 @default.
• W2042111313 hasConcept C142462285 @default.
• W2042111313 hasConcept C159047783 @default.
• W2042111313 hasConcept C181199279 @default.
• W2042111313 hasConcept C185592680 @default.
• W2042111313 hasConcept C24890656 @default.
• W2042111313 hasConcept C2522874641 @default.
• W2042111313 hasConcept C2776714187 @default.
• W2042111313 hasConcept C2781143361 @default.
• W2042111313 hasConcept C2993143319 @default.
• W2042111313 hasConcept C33923547 @default.
• W2042111313 hasConcept C55493867 @default.
• W2042111313 hasConcept C62231903 @default.
• W2042111313 hasConcept C86803240 @default.
• W2042111313 hasConcept C98274493 @default.
• W2042111313 hasConceptScore W2042111313C104317684 @default.
• W2042111313 hasConceptScore W2042111313C110121322 @default.
• W2042111313 hasConceptScore W2042111313C112705442 @default.
• W2042111313 hasConceptScore W2042111313C121332964 @default.
• W2042111313 hasConceptScore W2042111313C125287762 @default.

• next